2. Academic Validation
  3. 5-O-Methylvisammioside inhibits HMGB1-induced Angiogenesis of hepatocellular carcinoma through RAGE/MEK/ERK signaling pathway

5-O-Methylvisammioside inhibits HMGB1-induced Angiogenesis of hepatocellular carcinoma through RAGE/MEK/ERK signaling pathway

  • PLoS One. 2025 May 5;20(5):e0322056. doi: 10.1371/journal.pone.0322056.
Wenyue Hou 1,  Ting Zou 1,  Yichao Yan 1,  Yaolong Zhuang 1 2,  Shaomei Gao 1,  Huijun Ju 1,  Fei Yao 1 3,  Qin Yuan 1 3,  Liang Zhou 1 3,  Guoqiang Liang 1 3,  Xiudao Song 1 3,  Lurong Zhang 1 3
Affiliations

Affiliations

  • 1 Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
  • 2 College of Life Sciences, Xuzhou Medical University, Xuzhou, China.
  • 3 Suzhou Academy of Wu Men Chinese Medicine, Suzhou, China.
PMID: 40323970 DOI: 10.1371/journal.pone.0322056
Abstract

5-O-Methylvisammioside (5OMV), a flavonol compound derived from the traditional Chinese medicine plant Saposhnikovia divaricat, has been shown to inhibit vasospasm induced by High Mobility Group Box 1 (HMGB1) protein. However, its therapeutic potential and molecular mechanisms in HMGB1-induced tumor angiogenesis remain unexplored. Through comprehensive in vitro assays, we demonstrated that 5OMV significantly attenuates HMGB1-induced proliferation, migration, tube formation, and angiogenic activity in human umbilical vein endothelial cells (HUVECs). Parallel in vivo studies using an orthotopic hepatocellular carcinoma model in C57BL/6 mice revealed that 5OMV treatment markedly reduced tumor progression and microvascular density. Mechanistic studies identified that 5OMV downregulates both total and phosphorylated forms of RAGE, MEK, and ERK in HUVECs and tumor tissues. These findings collectively establish that 5OMV exerts anti-tumor effects in hepatocellular carcinoma through targeted modulation of the HMGB1/RAGE/MEK/ERK signaling axis.

Figures
Products